Home>Latest>News Posts>BioVale’s first pitch fest opportunity via the Bioeconomy Ventures Ambassador programme is launched

BioVale’s first pitch fest opportunity via the Bioeconomy Ventures Ambassador programme is launched

BioVale is proud to announce that is has been chosen by the EU-funded Bioeconomy Ventures programme to join twenty other organisations that are representing bioeconomy innovation agencies, accelerators, incubators, and innovation clusters across Europe.

Bioeconomy Ventures aim is to create a sustainable entrepreneurial ecosystem in the bio-industry sector bridging the gap between science, policy and people. They will act as a meeting point for the entrepreneurs and the investors’ communities (business angels; ventures capitalists), the project fosters their interaction and networking to relevant stakeholders.

As an ambassador of this programme, BioVale will organise at least two pitching and networking sessions in the Yorkshire and Humber region.  The goal is to boost European entrepreneurship at a local level by connecting start-ups, investors and to engage them with the Bioeconomy Ventures platform.

The first pitch fest opportunity for bio-based businesses to pitch their ideas to investors to will take place on Thursday 9th June 2022 in York. This is an opportunity to present to specialist investors who have an interest in this sector, raise the profile of your business to an audience at a high-profile event and win in a place to pitch to investors at the MPowerBio final pitch competition in Dusseldorf in October 2022.

To apply please send the pitch deck that you would use to support a 3 minute pitch to alice.north@york.ac.uk no later than 5pm on Thursday the 6th of May. Applicants will be notified if they have been awarded a place in the Pitch Event no later than Thursday the 12th of May.

This event is part of the THYME Project Successes and Opportunities for the Bioeconomy Across Yorkshire, Teesside and the Humber event.

Find out more about Bioeconomy Ventures. 

Bioeconomy Ventures has received funding from the Bio Based Industries Joint Undertaking under the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No 101023260.